Beam TherapeuticsInc Stock Financials


USD 43.18  1.19  2.68%   

Beam TherapeuticsInc Tangible Asset Value is relatively stable at the moment as compared to the past year. The company's current Tangible Asset Value is estimated at 1.59 Billion. Working Capital is expected to hike to about 1.1 B this year, although the value of Earnings Before Interest Taxes and Depreciation Amortization EBITDA will most likely fall to (373 M).
With this module, you can analyze Beam TherapeuticsInc financials for your investing period. You should be able to track the changes in Beam TherapeuticsInc individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Beam TherapeuticsInc Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Beam TherapeuticsInc's financial statements are interrelated, with each one affecting the others. For example, an increase in Beam TherapeuticsInc's assets may result in an increase in income on the income statement.


55.94 Million

The financial analysis of Beam TherapeuticsInc is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Beam TherapeuticsInc includes many different criteria found on its balance sheet. For example, investors should never minimize Beam TherapeuticsInc's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Beam TherapeuticsInc's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Beam TherapeuticsInc.

Beam TherapeuticsInc Cash

Chance Of Financial Distress
Less than 12
Beam TherapeuticsInc has less than 12 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Beam TherapeuticsInc stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Beam TherapeuticsInc's official financial statements usually reflect Beam TherapeuticsInc's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Beam TherapeuticsInc. For example, before you start analyzing numbers published by Beam TherapeuticsInc accountants, it's critical to develop an understanding of what Beam TherapeuticsInc's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Beam TherapeuticsInc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Beam TherapeuticsInc's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Beam TherapeuticsInc's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Beam TherapeuticsInc. Please utilize our Beneish M Score to check the likelihood of Beam TherapeuticsInc's management to manipulate its earnings.

Beam TherapeuticsInc Company Summary

Beam TherapeuticsInc competes with Johnson Johnson, Bondbloxx ETF, Fidelity MSCI, and Merck. Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. Beam Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 507 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CIK Number0001745999
RegionNorth America
Business Address238 Main Street,
IndustryHealth Care
BenchmarkNYSE Composite
Phone857 327 8775
CurrencyUSD - US Dollar
You should never invest in Beam TherapeuticsInc without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Beam TherapeuticsInc Stock, because this is throwing your money away. Analyzing the key information contained in Beam TherapeuticsInc's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Beam TherapeuticsInc Key Financial Ratios

Generally speaking, Beam TherapeuticsInc's financial ratios allow both analysts and investors to convert raw data from Beam TherapeuticsInc's financial statements into concise, actionable information that can be used to evaluate the performance of Beam TherapeuticsInc over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Beam TherapeuticsInc reports annually and quarterly.

Beam TherapeuticsInc Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Beam TherapeuticsInc's current stock value. Our valuation model uses many indicators to compare Beam TherapeuticsInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Beam TherapeuticsInc competition to find correlations between indicators driving Beam TherapeuticsInc's intrinsic value. More Info.
Beam TherapeuticsInc is number one stock in shares owned by institutions category among related companies. It is rated second in total asset category among related companies fabricating about  16,936,056  of Total Asset per Shares Owned by Institutions. Beam TherapeuticsInc Total Assets are relatively stable at the moment as compared to the past year. The company's current value of Total Assets is estimated at 1.59 Billion. Net Current Assets as percentage of Total Assets is expected to hike to 77.54 this year, although the value of Total Assets Per Share will most likely fall to 18.56.. Comparative valuation analysis is a catch-all model that can be used if you cannot value Beam TherapeuticsInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Beam TherapeuticsInc's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Beam TherapeuticsInc's earnings, one of the primary drivers of an investment's value.

Beam TherapeuticsInc Systematic Risk

Beam TherapeuticsInc's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Beam TherapeuticsInc volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Beam TherapeuticsInc correlated with the market. If Beta is less than 0 Beam TherapeuticsInc generally moves in the opposite direction as compared to the market. If Beam TherapeuticsInc Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Beam TherapeuticsInc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Beam TherapeuticsInc is generally in the same direction as the market. If Beta > 1 Beam TherapeuticsInc moves generally in the same direction as, but more than the movement of the benchmark.

About Beam TherapeuticsInc Financials

What exactly are Beam TherapeuticsInc Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Beam TherapeuticsInc's income statement, its balance sheet, and the statement of cash flows. Potential Beam TherapeuticsInc investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Beam TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in Beam TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Beam TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Beam TherapeuticsInc is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Beam TherapeuticsInc has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Beam TherapeuticsInc December 7, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Beam TherapeuticsInc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Beam TherapeuticsInc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Beam TherapeuticsInc based on widely used predictive technical indicators. In general, we focus on analyzing Beam TherapeuticsInc Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Beam TherapeuticsInc's daily price indicators and compare them against related drivers.
Information Ratio(0.05)
Maximum Drawdown21.81
Value At Risk(7.22)
Potential Upside7.32
Continue to Trending Equities. Note that the Beam TherapeuticsInc information on this page should be used as a complementary analysis to other Beam TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Beam TherapeuticsInc Stock analysis

When running Beam TherapeuticsInc price analysis, check to measure Beam TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beam TherapeuticsInc is operating at the current time. Most of Beam TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Beam TherapeuticsInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Beam TherapeuticsInc's price. Additionally, you may evaluate how the addition of Beam TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is Beam TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam TherapeuticsInc. If investors know Beam TherapeuticsInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Beam TherapeuticsInc is measured differently than its book value, which is the value of Beam TherapeuticsInc that is recorded on the company's balance sheet. Investors also form their own opinion of Beam TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Beam TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam TherapeuticsInc's market value can be influenced by many factors that don't directly affect Beam TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine Beam TherapeuticsInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.